(R)-7-(But-2-yn-1-yl)-8-(3-((7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione; 7-(But-2-yn-1-yl)-8-((3R)-3-((3-(but-2-yn-1-yl)-7-methyl-5-((4-methylquinazolin-2-yl)methyl)-4,6-dioxo-4,5,6,7-tetrahydro-3H-imidazo[4,5-c]pyridin-2-yl)amino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
Linagliptin Dimer N-Depiperidin-3-amine is a fully characterized chemical compound used as a reference standard of API Linagliptin. The standard offered is compliant with regulatory guidelines. Linagliptin Dimer N-Depiperidin-3-amine is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 2253964-98-4
